Soraya Wuillème
Soraya Wuillème publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Protein Degradation and Inhibitors.
- World rank
- #2,157,962 of 7,710,434 ranked researchers
- Rank in France
- #93,351 of 324,115
- Works
- 72
- Citations
- 2.5k
- Citations per work
- 34.1
What does Soraya Wuillème research?
Soraya Wuillème's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4156.6%
- Medicine4156.6%
- Everything else1824.5%
- Life Sciences1418.9%
- 1Hematology32% of their works
- 2Molecular Biology14% of their works
- 3Genetics11% of their works
- 4Oncology10% of their works
- 5Immunology5% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Protein Degradation and Inhibitors
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Which keywords describe Soraya Wuillème's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, Hematopoietic Stem Cells, Rituximab, Acute Myeloid Leukemia, AML and BET Bromodomains.
- Graft-versus-Host Disease
- BCR-ABL
- Classification
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- BET Bromodomains
- AML
- Hematopoietic Stem Cells
- International Myeloma Working Group
- Diagnosis Criteria
- Prognostic Factors
- Rituximab
- Acute Myeloid Leukemia
- PROTACs
- Genomic Aberrations
- Myelofibrosis
- Lymphoma
- Bone Marrow Niche
- Imatinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Diagnosis Criteria361 topic
- International Myeloma Working Group361 topic
- Prognostic Factors282 topics
- Hematopoietic Stem Cells232 topics
- Rituximab192 topics
- AML171 topic
- Acute Myeloid Leukemia171 topic
- BET Bromodomains121 topic
- PROTACs121 topic
- Chronic Lymphocytic Leukemia111 topic
- Genomic Aberrations111 topic
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- Classification81 topic
- Lymphoma81 topic
- BCR-ABL61 topic
- Bone Marrow Niche61 topic
- Graft-versus-Host Disease61 topic
- Imatinib61 topic
Where does Soraya Wuillème work?
Soraya Wuillème's main affiliation in the publication record is Centre Hospitalier Universitaire de Nantes, France.
How many publications and citations does Soraya Wuillème have?
OpenAlex counts 72 works and 2,458 citations for Soraya Wuillème, an h-index of 19, ranking #2,157,962 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Soraya Wuillème. Posts are plain text and can be reported.